Molecular immunologic approaches management bladder cancer heterogeneous nature bladder cancer various therapeutic options available management disease constant challenge clinicians variety new biologic approaches pathophysiology behavior tumors means clinical level Monoclonal antibodies immediate application diagnostic prognostic tools impact treatment patients bladder cancer 